New Frontiers in CIEDs: Leveraging Hemodynamic Data in Managing ICD Therapies and Heart Failure

Description

This session provides a concise understanding the mechanics of ICD therapies and HF diagnostics. Investigate the role of novel hemodynamic sensors to leapfrog the CIED technologies to improve clinical care of patients who need such devices.

Learning Objectives

Describe the current state of CIEDs in HF management.
Summarize the ICD shock therapies and limitations in differentiation between appropriate and inappropriate shocks.
Review applications of novel hemodynamic sensors in CIEDs in inappropriate shock mitigation and HF management.

Session Chair(s)

Dhanunjaya Lakkireddy, MBA, MD
Roy John, MD, PhD

Presentation

Clinical Outcomes After ICD Therapies
Presenter(s): Chandra S. Bomma, MD

Performance and Short-comings of Heart Failure Diagnostics in the Current Generation of CIEDs
Presenter(s): Niraj Varma, MA, MD, PhD

Current Diagnostic Algorithms and Their Real Life Performance in Transvenous, Subcutaneous, and Extravascular ICD Shock Therapies
Presenter(s): Mark W. Kroll, PhD

Role of Novel Embedded Hemodynamic Sensor Technology in Tachycardia Therapy Diagnostics and Mitigation of Inappropriate Shocks
Presenter(s): Jie Cheng, MD, PhD

Future Applications of Hemodynamic Data in HF Diagnosis and Management in Patients with CIEDs
Presenter(s): Nilesh Mathuria, MD

Disclosures

Chandra Bomma:

Johnson and Johnson (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

Niraj Varma:

EP Solutions (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))
Boston Scientific (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))
Biotronik (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))
Implicity (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))
Abbott (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))
Impulse Dynamics USA (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))

Mark Kroll:

Axon (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)

Jie Cheng:

Abbott (Research (Contracted Grants for PIs and Named Investigators only) - Independent Contractor (including contracted research))
Chelak Medical Solutions (Ownership/Partnership/Principal - Management Position)

Nilesh Mathuria:

Nothing Relevant to Disclose

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Ventricular Tachyarrhythmias
-- Implantable Cardioverter-defibrillators (ICDs)
-- 234. Skill to interrogate, program, and troubleshoot ICDs, including the appropriate use of anti-tachycardia pacing to minimize inappropriate, unnecessary, and recurrent shocks.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

Abstract Catalog 2025: ePosters

FREE